Tower Bridge Advisors Thermo Fisher Scientific Inc. Transaction History

Tower Bridge Advisors

$964 Billion
Q3 2024

A detailed history of Tower Bridge Advisors transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Tower Bridge Advisors holds 25,343 shares of TMO stock, worth $13.3 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

25,343

Previous 25,159 0.73%

Holding current value

$13.3 Million

Previous $13.9 Billion 12.68%

% of portfolio

1.63%

Previous 1.55%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$531.86 - $624.21 $97,862 - $114,854	184 Added 0.73%	25,343 $15.7 Billion
Q2 2024 Jul 24, 2024	SELL	$541.52 - $599.02 $1.6 Million - $1.77 Million	-2,961 Reduced 10.53%	25,159 $13.9 Billion
Q1 2024 Apr 29, 2024	SELL	$528.82 - $599.43 $2.47 Million - $2.81 Million	-4,680 Reduced 14.27%	28,120 $16.3 Billion
Q4 2023 Feb 14, 2024	SELL	$431.41 - $532.94 $106,126 - $131,103	-246 Reduced 0.74%	32,800 $17.4 Billion
Q3 2023 Nov 01, 2023	BUY	$498.29 - $574.41 $77,234 - $89,033	155 Added 0.47%	33,046 $16.7 Billion
Q2 2023 Jul 20, 2023	SELL	$508.46 - $591.13 $6.72 Million - $7.81 Million	-13,216 Reduced 28.66%	32,891 $17.2 Billion
Q1 2023 Apr 26, 2023	SELL	$535.0 - $604.82 $536,605 - $606,634	-1,003 Reduced 2.13%	46,107 $26.6 Billion
Q4 2022 Jan 27, 2023	BUY	$484.71 - $571.37 $168,679 - $198,836	348 Added 0.74%	47,110 $25.9 Billion
Q3 2022 Nov 14, 2022	SELL	$507.19 - $604.49 $56,298 - $67,098	-111 Reduced 0.24%	46,762 $23.7 Billion
Q2 2022 Jul 21, 2022	SELL	$500.9 - $612.21 $591,062 - $722,407	-1,180 Reduced 2.46%	46,873 $25.5 Billion
Q1 2022 May 05, 2022	SELL	$524.0 - $644.92 $127,332 - $156,715	-243 Reduced 0.5%	48,053 $28.4 Billion
Q4 2021 Feb 09, 2022	BUY	$569.0 - $667.24 $360,177 - $422,362	633 Added 1.33%	48,296 $32.2 Billion
Q3 2021 Oct 28, 2021	BUY	$509.53 - $609.78 $688,375 - $823,812	1,351 Added 2.92%	47,663 $27.2 Billion
Q2 2021 Aug 10, 2021	BUY	$441.0 - $508.24 $4.41 Million - $5.08 Million	9,998 Added 27.53%	46,312 $23.4 Billion
Q1 2021 May 12, 2021	BUY	$439.85 - $518.83 $543,214 - $640,755	1,235 Added 3.52%	36,314 $16.6 Billion
Q4 2020 Feb 11, 2021	BUY	$435.06 - $527.66 $3.29 Million - $3.99 Million	7,570 Added 27.52%	35,079 $16.3 Billion
Q3 2020 Nov 13, 2020	SELL	$359.77 - $441.52 $82,747 - $101,549	-230 Reduced 0.83%	27,509 $12.1 Billion
Q2 2020 Jul 22, 2020	SELL	$275.2 - $362.34 $100,448 - $132,254	-365 Reduced 1.3%	27,739 $10.1 Billion
Q1 2020 Apr 27, 2020	SELL	$255.3 - $340.05 $10,212 - $13,602	-40 Reduced 0.14%	28,104 $7.97 Billion
Q4 2019 Feb 05, 2020	SELL	$271.93 - $328.04 $1.05 Million - $1.27 Million	-3,870 Reduced 12.09%	28,144 $9.14 Billion
Q3 2019 Nov 12, 2019	SELL	$268.46 - $305.43 $88,591 - $100,791	-330 Reduced 1.02%	32,014 $9.43 Billion
Q2 2019 Aug 06, 2019	SELL	$257.51 - $295.55 $21,888 - $25,121	-85 Reduced 0.26%	32,344 $9.5 Billion
Q1 2019 Apr 30, 2019	BUY	$212.17 - $273.72 $19,095 - $24,634	90 Added 0.28%	32,429 $8.88 Billion
Q4 2018 Feb 07, 2019	BUY	$208.47 - $251.98 $103,192 - $124,730	495 Added 1.55%	32,339 $7.24 Billion
Q3 2018 Oct 23, 2018	SELL	$205.57 - $244.32 $14,389 - $17,102	-70 Reduced 0.22%	31,844 $7.77 Billion
Q2 2018 Aug 09, 2018	BUY	$203.14 - $219.53 $121,883 - $131,718	600 Added 1.92%	31,914 $6.61 Billion
Q1 2018 May 02, 2018	BUY	$192.98 - $224.11 $1.34 Million - $1.56 Million	6,950 Added 28.53%	31,314 $6.47 Billion
Q4 2017 Jan 30, 2018	BUY	$182.03 - $200.37 $335,845 - $369,682	1,845 Added 8.19%	24,364 $4.63 Billion
Q3 2017 Nov 06, 2017	BUY	$171.74 - $194.04 $3.87 Million - $4.37 Million	22,519	22,519 $4.26 Billion

Others Institutions Holding TMO

# of Institutions

2,835

Shares Held

333M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $206B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Bridge Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Tower Bridge Advisors with notifications on news.

Account

Tower Bridge Advisors Thermo Fisher Scientific Inc. Transaction History